NOROZARE Trademark

Trademark Overview

On Friday, February 8, 2019, a trademark application was filed for NOROZARE with the United States Patent and Trademark Office. The USPTO has given the NOROZARE trademark a serial number of 88295148. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 7, 2022. This trademark is owned by Takeda Vaccines, Inc.. The NOROZARE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
norozare

General Information

Serial Number88295148
Word MarkNOROZARE
Filing DateFriday, February 8, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 4, 2019

Trademark Statements

Goods and ServicesVaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 4, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTakeda Vaccines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameTakeda Vaccines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Monday, March 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 18, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 18, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 4, 2021EXTENSION 4 GRANTED
Tuesday, May 4, 2021EXTENSION 4 FILED
Tuesday, May 4, 2021TEAS EXTENSION RECEIVED
Wednesday, September 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 14, 2020EXTENSION 3 GRANTED
Monday, September 14, 2020EXTENSION 3 FILED
Monday, September 14, 2020TEAS EXTENSION RECEIVED
Friday, June 26, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 26, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 26, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 26, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 26, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 23, 2020EXTENSION 2 GRANTED
Tuesday, June 23, 2020EXTENSION 2 FILED
Tuesday, June 23, 2020TEAS EXTENSION RECEIVED
Saturday, January 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 2, 2020EXTENSION 1 GRANTED
Thursday, January 2, 2020EXTENSION 1 FILED
Thursday, January 2, 2020TEAS EXTENSION RECEIVED
Monday, September 23, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 23, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 30, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 8, 2019ASSIGNED TO EXAMINER
Tuesday, June 4, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 15, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 22, 2019ASSIGNED TO EXAMINER
Monday, March 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 12, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

norozare human vaccines